Stock
FOGHORN THERAPEUTICS
tastytradeTrade FHTX
FHTX Insider Trades:
Created with Highcharts 10.1.0PriceVolumeJan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '2504812162024060k120k180k240k300k360k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-01
2025-05-02
GALLAGHER NEIL
A - Grant
Stock Options (Right to buy)
50,000
$4.00
200K
1
$230.77M
2025-05-01
2025-05-02
DUTY STUART
A - Grant
Stock Options (Right to buy)
50,000
$4.00
200K
1
$230.77M
2025-04-25
2025-04-28
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-300K
$0.00
1
$230.77M
2025-04-25
2025-04-28
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
300K
$0.00
1
$230.77M
2025-04-09
2025-04-10
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
198K
$0.00
1
$230.77M
2025-04-09
2025-04-10
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-198K
$0.00
1
$230.77M
2025-01-22
2025-01-24
RIVKIN ANNA
Chief Business Officer
A - Grant
Stock Option (right to buy)
50,000
$4.00
200K
1
$230.77M
2025-01-22
2025-01-24
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
115K
$4.00
460K
1
$230.77M
2025-01-22
2025-01-24
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
140K
$4.00
560K
1
$230.77M
2025-01-22
2025-01-24
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Option (right to buy)
125K
$4.00
500K
1
$230.77M
2025-01-22
2025-01-24
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
400K
$4.00
1.60M
1
$230.77M
2025-01-22
2025-01-24
HUMER KRISTIAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
120K
$4.00
480K
1
$230.77M
2025-01-22
2025-01-24
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
126K
$4.00
504K
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-857
$0.00
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-857
$10.00
-8,570
1
$230.77M
2024-09-23
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
857
$4.00
3,428
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-35,756
$10.00
-358K
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-35,756
$0.00
1
$230.77M
2024-09-20
2024-09-24
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
35,756
$4.00
143K
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-11,574
$0.00
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
11,574
$4.00
46,296
1
$230.77M
2024-09-18
2024-09-20
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-11,574
$10.00
-116K
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-10,272
$0.00
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
10,272
$4.00
41,088
1
$230.77M
2024-09-17
2024-09-18
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-10,272
$10.00
-103K
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Stock Option (right to buy)
-400
$0.00
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
M - Exercise
Common Stock
400
$4.00
1,600
1
$230.77M
2024-09-16
2024-09-18
COSTA CARLOS
Chief People Officer
S - Sale
Common Stock
-400
$10.00
-4,000
1
$230.77M
2024-09-16
2024-09-16
COSTA CARLOS
Chief People Officer
S - Sale
-98,648
$10.00
-986K
1
$230.77M
2024-09-09
2024-09-11
BELLON STEVEN
Chief Scientific Officer
S - Sale
Common Stock
-20,000
$10.00
-200K
1
$230.77M
2024-09-03
2024-09-04
RIVKIN ANNA
Chief Business Officer
A - Grant
Stock Options (Right to buy)
190K
$8.00
1.52M
1
$230.77M
2024-06-26
2024-06-28
KOPPEL ADAM
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
BILLER SCOTT
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
COLE DOUGLAS
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
GILL SIMBA
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
LYNCH THOMAS JR.
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
MENDELSOHN MICHAEL
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
PARSHALL LYNNE
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-06-26
2024-06-28
SMITH IAN
A - Grant
Stock Options (Right to buy)
16,000
$6.00
96,000
1
$230.77M
2024-05-22
2024-05-24
FLAGSHIP PIONEERING INC.
P - Purchase
Pre-Funded Warrants to purchase Common Stock
3.63M
$6.00
22M
2
$230.77M
2024-04-16
2024-04-17
HUMER KRISTIAN
Chief Financial Officer
A - Grant
Stock Option (Right to buy)
275K
$6.00
1.65M
1
$230.77M
2024-03-11
2024-03-12
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
S - Sale
Common Stock
-11,000
$7.00
-77,000
1
$230.77M
2024-01-24
2024-01-25
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
110K
$3.00
330K
1
$230.77M
2024-01-24
2024-01-25
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Option (right to buy)
60,000
$3.00
180K
1
$230.77M
2024-01-24
2024-01-25
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
A - Grant
Stock Option (right to buy)
80,000
$3.00
240K
1
$230.77M
2024-01-24
2024-01-25
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
90,000
$3.00
270K
1
$230.77M
2024-01-24
2024-01-25
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
300K
$3.00
900K
1
$230.77M
2024-01-24
2024-01-25
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
100K
$3.00
300K
1
$230.77M
2023-12-08
2023-12-12
SMITH IAN
A - Grant
Stock Option (right to buy)
26,977
$0.00
1
$230.77M
2023-09-11
2023-09-13
CARDAMA ALFONSO QUINTAS
Chief Medical Officer
A - Grant
Stock Options (Right to buy)
272K
$8.00
2.18M
1
$230.77M
2023-08-17
2023-08-18
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-63,000
$0.00
1
$230.77M
2023-08-17
2023-08-18
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
63,000
$0.00
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
S - Sale
Common Stock
-311K
$8.00
-2.49M
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-311K
$0.00
1
$230.77M
2023-08-16
2023-08-18
AGRESTA SAMUEL
Chief Medical Officer
M - Exercise
Common Stock
311K
$4.00
1.25M
1
$230.77M
2023-06-21
2023-06-22
BILLER SCOTT
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
COLE DOUGLAS
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
GILL SIMBA
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
KOPPEL ADAM
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
LYNCH THOMAS JR.
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
MENDELSOHN MICHAEL
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
PARSHALL LYNNE
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-06-21
2023-06-22
SMITH IAN
A - Grant
Stock Option (right to buy)
16,000
$0.00
1
$230.77M
2023-05-26
2023-05-31
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
300K
$0.00
1
$230.77M
2023-05-26
2023-05-31
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-300K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
-185K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
185K
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-4,371
$0.00
1
$230.77M
2023-02-17
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
4,371
$0.00
1
$230.77M
2022-10-25
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
-4,371
$0.00
1
$230.77M
2022-10-25
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
J - Other
Common Stock
4,371
$0.00
1
$230.77M
2022-02-10
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
-123K
$0.00
1
$230.77M
2022-02-10
2023-02-22
GOTTSCHALK ADRIAN
Chief Executive Officer
G - Gift
Common Stock
123K
$0.00
1
$230.77M
2023-01-26
2023-01-30
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$230.77M
2023-01-26
2023-01-30
CAVALIE FANNY
Chief Strategy/Bus Ops Officer
A - Grant
Stock Option (right to buy)
65,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
65,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
90,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
90,000
$0.00
1
$230.77M
2023-01-26
2023-01-30
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
280K
$0.00
1
$230.77M
2023-01-26
2023-01-30
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$230.77M
2022-10-27
2022-10-31
LYNCH THOMAS JR.
A - Grant
Stock Options (Right to buy)
32,000
$8.00
256K
1
$230.77M
2022-09-16
2022-09-19
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-40,000
$0.00
1
$230.77M
2022-09-16
2022-09-19
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Common Stock
40,000
$1.00
40,000
1
$230.77M
2022-09-13
2022-09-14
GILL SIMBA
G - Gift
Common Stock
-47,939
$0.00
1
$230.77M
2022-09-12
2022-09-14
GILL SIMBA
M - Exercise
Common Stock
82,000
$1.00
82,000
1
$230.77M
2022-09-12
2022-09-14
GILL SIMBA
M - Exercise
Stock Options (Right to buy)
-82,000
$0.00
1
$230.77M
2022-08-16
2022-08-18
PARSHALL LYNNE
A - Grant
Stock Options (Right to buy)
32,000
$16.00
512K
1
$230.77M
2022-08-11
2022-08-15
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-1,858
$0.00
1
$230.77M
2022-08-11
2022-08-15
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Common Stock
1,858
$4.00
7,432
1
$230.77M
2022-08-01
2022-08-03
COSTA CARLOS
Chief People Officer
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
BILLER SCOTT
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
COLE DOUGLAS
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
GILL SIMBA
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
KADOCH CIGALL
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
KOPPEL ADAM
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
MENDELSOHN MICHAEL
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-06-21
2022-06-22
SMITH IAN
A - Grant
Stock Options (Right to buy)
16,000
$0.00
1
$230.77M
2022-05-25
2022-05-27
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-4,392
$0.00
2
$230.77M
2022-05-25
2022-05-27
BELLON STEVEN
Chief Scientific Officer
M - Exercise
Common Stock
4,392
$3.00
13,176
2
$230.77M
2022-01-26
2022-01-28
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
135K
$0.00
1
$230.77M
2022-01-26
2022-01-28
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
125K
$0.00
1
$230.77M
2022-01-26
2022-01-28
BELLON STEVEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
150K
$0.00
1
$230.77M
2022-01-26
2022-01-28
GOTTSCHALK ADRIAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
440K
$0.00
1
$230.77M
2022-01-26
2022-01-28
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (right to buy)
135K
$0.00
1
$230.77M
2021-12-14
2021-12-16
KADOCH CIGALL
G - Gift
Common Stock
-333K
$0.00
1
$230.77M
2021-12-09
2021-12-13
DECICCO CARL
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-104K
$0.00
2
$230.77M
2021-12-09
2021-12-13
DECICCO CARL
Chief Scientific Officer
M - Exercise
Common Stock
104K
$4.00
417K
1
$230.77M
2021-08-20
2021-08-23
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-23,000
$0.00
1
$230.77M
2021-08-20
2021-08-23
GOTTSCHALK ADRIAN
Chief Executive Officer
M - Exercise
Common Stock
23,000
$1.00
23,000
1
$230.77M
2021-08-09
2021-08-11
REINE ALLAN
Chief Financial Officer
M - Exercise
Stock Options (Right to buy)
26,892
$0.00
1
$230.77M
2021-08-09
2021-08-11
REINE ALLAN
Chief Financial Officer
M - Exercise
Common Stock
26,892
$4.00
108K
1
$230.77M
2021-07-13
2021-07-14
BILLER SCOTT
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-07-13
2021-07-14
COLE DOUGLAS
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-07-13
2021-07-14
GILL SIMBA
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-07-13
2021-07-14
KADOCH CIGALL
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-07-13
2021-07-14
KOPPEL ADAM
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-07-13
2021-07-14
MENDELSOHN MICHAEL
A - Grant
Stock Option (right to buy)
12,530
$0.00
1
$230.77M
2021-06-23
2021-06-24
SMITH IAN
A - Grant
Stock Options (Right to buy)
12,530
$0.00
1
$230.77M
2021-04-27
2021-04-29
SMITH IAN
A - Grant
Stock Options (Right to buy)
25,060
$12.00
301K
1
$230.77M
2021-01-28
2021-02-01
AGRESTA SAMUEL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$230.77M
2021-01-28
2021-02-01
DECICCO CARL
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$230.77M
2021-01-28
2021-02-01
GOTTSCHALK ADRIAN
President & Chief Executive Of...
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$230.77M
2021-01-28
2021-02-01
REINE ALLAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$230.77M
2020-11-17
2020-11-18
LACASCIA MICHAEL
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
162K
$0.00
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series A-1 Convertible Preferred Stock
-7.50M
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series A-2 Convertible Preferred Stock
-8.33M
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Series B Convertible Preferred Stock
-7.34M
3
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
C - Conversion
Common Stock
13M
5
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Series A-2 Convertible Preferred Stock
-18,018
1
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Series B Convertible Preferred Stock
-7,207
1
$230.77M
2020-10-27
2020-10-29
GOTTSCHALK ADRIAN
President & Chief Executive Of...
C - Conversion
Common Stock
25,225
1
$230.77M
2020-10-27
2020-10-29
DECICCO CARL
Chief Scientific Officer
P - Purchase
Common Stock
5,500
$16.00
88,000
1
$230.77M
2020-10-27
2020-10-29
FLAGSHIP VENTURES FUND GENERAL PARTNER LLC
P - Purchase
Common Stock
150K
$16.00
2.40M
3
$230.77M
2020-10-27
2020-10-28
ABU DHABI INVESTMENT AUTHORITY
C - Conversion
Series B Preferred Stock
-2.00M
1
$230.77M
2020-10-27
2020-10-28
ABU DHABI INVESTMENT AUTHORITY
C - Conversion
Common Stock
1.08M
1
$230.77M
2020-10-27
2020-10-28
ABU DHABI INVESTMENT AUTHORITY
P - Purchase
Common Stock
150K
$16.00
2.40M
1
$230.77M